These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 26496203)

  • 1. A Novel Strategy for Detection and Enumeration of Circulating Rare Cell Populations in Metastatic Cancer Patients Using Automated Microfluidic Filtration and Multiplex Immunoassay.
    Magbanua MJ; Pugia M; Lee JS; Jabon M; Wang V; Gubens M; Marfurt K; Pence J; Sidhu H; Uzgiris A; Rugo HS; Park JW
    PLoS One; 2015; 10(10):e0141166. PubMed ID: 26496203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated Microfluidic Filtration and Immunocytochemistry Detection System for Capture and Enumeration of Circulating Tumor Cells and Other Rare Cell Populations in Blood.
    Pugia M; Magbanua MJM; Park JW
    Methods Mol Biol; 2017; 1634():119-131. PubMed ID: 28819845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enrichment and Detection of Circulating Tumor Cells and Other Rare Cell Populations by Microfluidic Filtration.
    Pugia M; Magbanua MJM; Park JW
    Adv Exp Med Biol; 2017; 994():119-131. PubMed ID: 28560671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly sensitive enumeration of circulating tumor cells in lung cancer patients using a size-based filtration microfluidic chip.
    Huang T; Jia CP; Jun-Yang ; Sun WJ; Wang WT; Zhang HL; Cong H; Jing FX; Mao HJ; Jin QH; Zhang Z; Chen YJ; Li G; Mao GX; Zhao JL
    Biosens Bioelectron; 2014 Jan; 51():213-8. PubMed ID: 23962709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in enumeration of CTCs in breast cancer using techniques independent of cytokeratin expression.
    Castle J; Morris K; Pritchard S; Kirwan CC
    PLoS One; 2017; 12(4):e0175647. PubMed ID: 28422972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.
    Huebner H; Fasching PA; Gumbrecht W; Jud S; Rauh C; Matzas M; Paulicka P; Friedrich K; Lux MP; Volz B; Gass P; Häberle L; Meier-Stiegen F; Hartkopf A; Neubauer H; Almstedt K; Beckmann MW; Fehm TN; Ruebner M
    BMC Cancer; 2018 Feb; 18(1):204. PubMed ID: 29463222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of circulating tumor cell enumeration and HER2 expression by a novel automated microfluidic system in metastatic breast cancer.
    Wang L; Hong R; Shi S; Wang S; Chen Y; Han C; Li M; Ye F
    BMC Cancer; 2024 Aug; 24(1):1067. PubMed ID: 39210288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct expression of cytokeratin, N-cadherin and CD133 in circulating tumor cells of metastatic breast cancer patients.
    Bock C; Rack B; Huober J; Andergassen U; Jeschke U; Doisneau-Sixou S
    Future Oncol; 2014 Aug; 10(10):1751-65. PubMed ID: 25303055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.
    Giordano A; Gao H; Anfossi S; Cohen E; Mego M; Lee BN; Tin S; De Laurentiis M; Parker CA; Alvarez RH; Valero V; Ueno NT; De Placido S; Mani SA; Esteva FJ; Cristofanilli M; Reuben JM
    Mol Cancer Ther; 2012 Nov; 11(11):2526-34. PubMed ID: 22973057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
    Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
    J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of circulating tumor cells from lung cancer patients using microfluidic chip.
    Qian C; Wu S; Chen H; Zhang X; Jing R; Shen L; Wang X; Ju S; Jia C; Cong H
    Clin Exp Med; 2018 May; 18(2):191-202. PubMed ID: 29445889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients.
    Kim SJ; Masago A; Tamaki Y; Akazawa K; Tsukamoto F; Sato J; Ozawa T; Tsujino Y; Noguchi S
    Breast Cancer Res Treat; 2011 Aug; 128(3):765-73. PubMed ID: 21630023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
    Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
    Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.
    Mikulová V; Cabiňaková M; Janatková I; Mestek O; Zima T; Tesařová P
    Scand J Clin Lab Invest; 2014 Mar; 74(2):132-42. PubMed ID: 24350991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer.
    Pirozzi G; Tirino V; Camerlingo R; La Rocca A; Martucci N; Scognamiglio G; Franco R; Cantile M; Normanno N; Rocco G
    Oncol Rep; 2013 May; 29(5):1763-8. PubMed ID: 23426441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Impact of Circulating Tumor Cell Detected Using a Novel Fluidic Cell Microarray Chip System in Patients with Breast Cancer.
    Sawada T; Araki J; Yamashita T; Masubuchi M; Chiyoda T; Yunokawa M; Hoshi K; Tao S; Yamamura S; Yatsushiro S; Abe K; Kataoka M; Shimoyama T; Maeda Y; Kuroi K; Tamura K; Sawazumi T; Minami H; Suda Y; Koizumi F
    EBioMedicine; 2016 Sep; 11():173-182. PubMed ID: 27495793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ultra-high-throughput spiral microfluidic biochip for the enrichment of circulating tumor cells.
    Warkiani ME; Khoo BL; Tan DS; Bhagat AA; Lim WT; Yap YS; Lee SC; Soo RA; Han J; Lim CT
    Analyst; 2014 Jul; 139(13):3245-55. PubMed ID: 24840240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of circulating tumor cells in breast cancer.
    Broersen LH; van Pelt GW; Tollenaar RA; Mesker WE
    Cell Oncol (Dordr); 2014 Feb; 37(1):9-15. PubMed ID: 24249155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patients.
    Yagi S; Koh Y; Akamatsu H; Kanai K; Hayata A; Tokudome N; Akamatsu K; Endo K; Nakamura S; Higuchi M; Kanbara H; Nakanishi M; Ueda H; Yamamoto N
    PLoS One; 2017; 12(6):e0179744. PubMed ID: 28640869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Method for semi-automated microscopy of filtration-enriched circulating tumor cells.
    Pailler E; Oulhen M; Billiot F; Galland A; Auger N; Faugeroux V; Laplace-Builhé C; Besse B; Loriot Y; Ngo-Camus M; Hemanda M; Lindsay CR; Soria JC; Vielh P; Farace F
    BMC Cancer; 2016 Jul; 16():477. PubMed ID: 27417942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.